Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  PAREXEL International Corporation    PRXL   US6994621075

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo PAREXEL International Corp
Provides clinical research and development services

PAREXEL International Corp. is a biopharmaceutical services company, which provides clinical research, clinical logistics, medical communications, consulting, commercialization and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.

The company operates its business through three segments: Clinical Research Services, PAREXEL Consulting & Medical Communication Services and Perceptive Informatics.

The Clinical Research Services segment includes services such as clinical trials management and biostatistics, data management, clinical pharmacology, as well as related medical advisory, patient recruitment, clinical supply and drug logistics, pharmacovigilance, and investigator site services.

The PAREXEL Consulting & Medical Communication Services segment provides a spectrum of market development, product development and targeted communications services in support of product launch.

The Perceptive Informatics segment provides information technology solutions designed to improve client's product development processes.

The segments portfolio of products and services includes ClinPhone RTSM, IMPACT CTMS, DataLabs EDC, web-based portals, systems integration, electronic patient reported outcomes and LIQUENT InSight Regulatory Information Management platform.PAREXEL International was founded by Josef H. von Rickenbach and Anne B. Sayigh in 1982 and is headquartered in Waltham, MA.

Number of employees : 15 560 persons.
Sales per Businesses
201220132014
USD (in Million)%USD (in Million)%USD (in Million)%
Clinical Research Services1,03964.2%1,30465.3%1,45564.2%
Perceptive190.6811.8%228.3511.4%267.9011.8%
Paraxel Consulting and Medical Communications Services167.1310.3%202.5210.1%216.189.5%
Sales per Regions
201220132014
USD (in Million)%USD (in Million)%USD (in Million)%
The Americas635.2939.3%867.0043.4%970.8942.8%
Europe, Middle East & Africa555.4734.3%624.0131.3%709.1431.3%
Asia/Pacific205.7512.7%243.4312.2%259.3311.4%
Managers
NameAgeSinceTitle
Josef H. von Rickenbach, MBA591982Chairman & Chief Executive Officer
Mark A. Goldberg, MD541997President & Chief Operating Officer
Ingo Bank, MBA462013Chief Financial Officer & Senior Vice President
Thomas Senderovitz, MD49-Senior Vice President-Clinical Research Services
Peter Steiger, PhD-2014Chief Scientific Officer & Vice President
Sy Pretorius, MD--Chief Scientific Officer & Vice President
A. Dana Callow Jr., MBA621986Independent Director
Pat J. Fortune PhD, MBA671996Independent Director
Richard L. Love702002Independent Director
Ellen M. Zane622006Independent Director
Shareholders
NameShares%
Wellington Management Co. LLP 5,902,782 10.7%
BlackRock Fund Advisors 4,371,634 7.95%
The Vanguard Group, Inc. 4,239,273 7.71%
Fisher Asset Management LLC 2,427,492 4.41%
Acadian Asset Management LLC 2,147,771 3.90%
Fidelity Management & Research Co. 1,766,745 3.21%
Neuberger Berman LLC 1,740,325 3.16%
Schroder Investment Management North America, Inc. 1,507,082 2.74%
SSgA Funds Management, Inc. 1,266,431 2.30%
Geneva Capital Management LLC 1,197,480 2.18%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
PHARMACYCLICS, IN..
INCYTE CORPORATIO..
ALKERMES PLC
ALNYLAM PHARMACEU..
QUINTILES TRANSNA..
UNITED THERAPEUTI..
ISIS PHARMACEUTIC..
PUMA BIOTECHNOLOG..
-
CELLTRION, INC.
QIAGEN NV
INTREXON CORP
SEATTLE GENETICS,..
ICON PLC
PAREXEL INTERNATI..
CHARLES RIVER LAB..
BIO-TECHNE CORP
BB BIOTECH AG
-
SYNAGEVA BIOPHARM..
ACADIA PHARMACEUT..
WUXI PHARMATECH (..
Sector Biotechnology & Medical Research
PAREXEL International Corp : Connections
Association of Clinical Research Organizations
Syndevrx, Inc.
Harvard School of Public Health
Salutaris Medical Devices, Inc.
Grünenthal GmbH
PAREXEL Informatics, Inc.
New England Healthcare Institute
PAREXEL International Ltd.
Caris Molecular Profiling Institute, Inc.
The Floating Hospital, Inc.
TVP Management Co. LLC
MedAptus, Inc.
Tufts University
Jobs for Massachusetts, Inc.
Press Ganey Associates, Inc.
MedTrust Online LLC
CerRx, Inc.
PHT Technologies, Inc.
The Leukemia & Lymphoma Society
Applied Microarrays, Inc.
CardioMEMS, Inc.
Ascalon International, Inc.
GlycoFi, Inc.
MedTrust LLC
Epigenesis Pharmaceuticals LLC
Cancer Prevention Pharmaceuticals LLC
Sapphire Therapeutics, Inc.
Translational Accelerators LLC
University of Wisconsin Foundation
University of Illinois
Tufts Medical Center, Inc.
Sun Mountain Capital LLC
Century Capital Management, Inc.
Cleveland Clinic Innovations
Floating Hospital For Children
Company contact information
PAREXEL International Corp.
195 West Street
Waltham, MA 02451-1111

Phone : +1.781.487.9900
Fax : +1.781.487.0525
Web : www.parexel.com
© 2015 People , Fundamentals and Ownership   
Dynamic quotes  
ON
| OFF